Sotera Health (SHC) Projected to Post Earnings on Thursday

Sotera Health (NASDAQ:SHC) is expected to be issuing its Q1 2026 results before the market opens on Thursday, April 30th. Analysts expect the company to announce earnings of $0.17 per share and revenue of $270.8120 million for the quarter. Sotera Health has set its FY 2026 guidance at 0.930-1.01 EPS. Parties are encouraged to explore the company’s upcoming Q1 2026 earning overview page for the latest details on the call scheduled for Tuesday, May 5, 2026 at 9:00 AM ET.

Sotera Health (NASDAQ:SHC) last released its quarterly earnings data on Tuesday, February 24th. The company reported $0.26 EPS for the quarter, topping analysts’ consensus estimates of $0.24 by $0.02. The company had revenue of $303.44 million for the quarter, compared to the consensus estimate of $300.68 million. Sotera Health had a return on equity of 42.38% and a net margin of 6.70%.The company’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same period last year, the business posted $0.21 EPS. On average, analysts expect Sotera Health to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Sotera Health Stock Performance

Sotera Health stock opened at $15.63 on Thursday. The stock’s 50-day moving average is $15.24 and its 200-day moving average is $16.50. The company has a market cap of $4.46 billion, a price-to-earnings ratio of 57.89 and a beta of 1.88. The company has a debt-to-equity ratio of 3.66, a current ratio of 2.46 and a quick ratio of 2.24. Sotera Health has a 12 month low of $10.68 and a 12 month high of $19.85.

Insider Buying and Selling

In related news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the business’s stock in a transaction that occurred on Friday, March 6th. The stock was sold at an average price of $15.27, for a total transaction of $152,700,000.00. Following the transaction, the director directly owned 12,735,301 shares of the company’s stock, valued at approximately $194,468,046.27. The trade was a 43.98% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 47.55% of the company’s stock.

Hedge Funds Weigh In On Sotera Health

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Vident Advisory LLC lifted its position in Sotera Health by 23.9% during the 2nd quarter. Vident Advisory LLC now owns 17,419 shares of the company’s stock worth $194,000 after acquiring an additional 3,364 shares in the last quarter. Integrated Wealth Concepts LLC purchased a new stake in Sotera Health during the 4th quarter worth approximately $192,000. Utah Retirement Systems purchased a new stake in Sotera Health during the 4th quarter worth approximately $191,000. Amundi purchased a new stake in Sotera Health during the 4th quarter worth approximately $179,000. Finally, Maryland State Retirement & Pension System purchased a new stake in Sotera Health during the 4th quarter worth approximately $176,000. 91.03% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

SHC has been the topic of a number of research reports. Wall Street Zen downgraded Sotera Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 11th. Barclays cut their price objective on Sotera Health from $20.00 to $18.00 and set an “overweight” rating on the stock in a report on Tuesday, April 14th. Citigroup raised their price objective on Sotera Health from $21.00 to $23.00 and gave the stock a “buy” rating in a report on Tuesday, February 24th. Royal Bank Of Canada initiated coverage on Sotera Health in a report on Thursday, January 8th. They issued an “outperform” rating and a $24.00 price objective on the stock. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Sotera Health in a research report on Monday, December 29th. Eight equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $20.14.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.